Catalog Advanced Search

Search by Category
Search by Format
Sort By
Search by Type
Search by Keyword
Search by Category
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Contains 4 Component(s), Includes Credits Includes a Live Web Event on 12/20/2023 at 12:00 PM (EST)

    Details Coming Soon!

    More details coming soon!

  • Contains 4 Component(s), Includes Credits Includes a Live Web Event on 11/15/2023 at 12:00 PM (EST)

    Details Coming Soon!

    More details coming soon.

    Jonathan Ogurchak, PharmD, CSP

    Co-Founder & CEO

    STACK

    Jonathan Ogurchak is the Founder & CEO of STACK, a compliance management software designed to simplify the “outside of the dispense” complexities associated with running successful pharmacy organizations. He is also Managing Partner of Rhythm Group, consulting and technology solutions organization, and is a Certified Consultant with Accreditation Commission for Health Care (ACHC). Jonathan has designed programs and services for both Accredo and PANTHERx Specialty Pharmacy focusing on implementing innovative uses for technology, including high-touch pharmacist-driven programs focused on dosing efficiency, clinical monitoring of patient outcomes, and integrated patient engagement. Jonathan is on faculty for the Master of Pharmacy Business Administration (MPBA) program through the University of Pittsburgh, leading the Specialty Pharmacy Management curriculum. He currently serves on the editorial board for Specialty Pharmacy Times, holds CSP Certification through the Specialty Pharmacy Certification Board, and serves as an Educational Consultant for the National Association of Specialty Pharmacy (NASP). 

    No Disclosures to Report

  • Contains 4 Component(s), Includes Credits Includes a Live Web Event on 10/18/2023 at 12:00 PM (EDT)

    Details Coming Soon!

    More details coming soon!

  • Contains 4 Component(s), Includes Credits Includes a Live Web Event on 09/20/2023 at 12:00 PM (EDT)

    Details Coming Soon!

    More details coming soon!

    Michelle Simpson, PharmD, BCSCP, MWC

    Clinical Program Manager

    National Home Infusion Association

    Michelle C. Simpson, PharmD, BCSCP, MWC, is a Board Certified Sterile Compounding Pharmacist with an established career in home infusion. She is the Clinical Program Manager for the National Home Infusion Association (NHIA), where she is responsible for research studies, non-profit foundation initiatives, data benchmarking, and clinical education development. Michelle is Editor in Chief of Infusion Journal, a peer-reviewed scholarly publication that features independent original research on infusion therapies and is published by the National Home Infusion Foundation (NHIF). Michelle is Editor of Extended Stability for Parenteral Drugs, 7th Edition, a publication of the American Society of Health-System Pharmacists (ASHP). 

    No Disclosures to Report

  • Contains 4 Component(s), Includes Credits Includes a Live Web Event on 08/16/2023 at 12:00 PM (EDT)

    Details Coming Soon!

    More details coming soon!

  • Contains 4 Component(s), Includes Credits Includes a Live Web Event on 07/19/2023 at 12:00 PM (EDT)

    Details Coming Soon!

    More details coming soon.

  • Contains 4 Component(s), Includes Credits Includes a Live Web Event on 06/21/2023 at 12:00 PM (EDT)

    Details Coming Soon!

    More details coming soon.

  • Contains 2 Component(s) Recorded On: 05/24/2023

    Learn how a comprehensive, integrated solution can solve the challenges of communication and care team coordination across your patients' entire care journey, including accelerated speed to therapy, increased revenue retention, and improved adherence.

    Learn how a comprehensive, integrated solution can solve the challenges of communication and care team coordinator across your patients' entire care journey, including accelerated speed to therapy, increased revenue retention, and improved adherence. From clinical and non-clinical frontlike workers to c-suite leadership, you will understand how the entire organization can benefit from an all-in-one digital solution that provides a powerful return on investment by saving essential time, improving compliance and documentation accuracy, and increasing operational efficiency, all while integrating into your pharmacy dispensing system. 

    Learning Objectives:

    • Understand how a comprehensive, digital solution provides a powerful return on investment by saving essential time, improving compliance and documentation accuracy, and increasing operational efficiency. 
    • Learn how to accelerate your speed to therapy, increase revenue retention, and improve patient adherence. 
    • Explore ways to improve communication and care team coordination across your patients' entire care journey.

    Sponsored by CitusHealth

    Jackie Owen, RN, BSN

    Clinical Product Specialist

    Citus Health

    Jackie Owen is an RN, BSN and Clinical Product Specialist for CitusHealth, with prior roles in sales, accounts, RN infusion management and as director of ambulatory infusion centers. Her range of experience is why she understands the need for a great patient engagement and internal communication collaboration platform. With 15 years as an RN in acute, post-acute and primary home infusion — and a previous customer of CitusHealth — Jackie is passionate about the CitusHealth system and enjoys sharing the benefits with current and potential customers.

    No Disclosures to Report

  • Contains 4 Component(s), Includes Credits Recorded On: 05/17/2023

    This presentation will look at enteral shortages through a homecare lens, discussing the current state of enteral shortages and how that is impacting enteral consumers and providers.

    This presentation will look at enteral shortages through a homecare lens, discussing the current state of enteral shortages and how that is impacting enteral consumers and providers. You will learn how one homecare provider has approached management of the enteral shortages and discuss strategies for how the healthcare industry can work together to help mitigate enteral consumer impacts in times of product shortages.  

    Learning Objectives:

    1. Explain the current state of enteral shortages in the homecare space.
    2. Understand one homecare approach to navigating challenges created by enteral shortages.
    3. Discuss best practices for navigating the current shortages to mitigate gaps in nutritional availability for enteral consumers.






    Janelle Flaherty

    RD, CNSC

    Coram CVS Specialty Infusion Services

    Janelle Flaherty (RD, CNSC) has worked in the homecare space for enteral nutrition for 14 years. She is the Manager of the Enteral Dietitian Team who provide care for Coram tube feeding patients. She also helps to manage Coram’s enteral product inventory working closely with distributors and manufacturer partners to evaluate products and manage supply chain changes and challenges.

    No Disclosures to Report

  • Contains 2 Component(s)

    Join Connie Sullivan, President and CEO of the National Home Infusion Association as she describes the driving forces behind the latest industry trends and discusses events that will impact infusion providers over the next five years.

    In this Talk Infusion webinar, learn about the first new home infusion HCPCS code in over 20 years, which is for injectable immunotherapies, and about NHIA's ongoing efforts to modernize the commercial code set. NHIA staff will also provide updates on recent and future engagement efforts with commercial payors designed to help health plans and their beneficiaries get the most out of home infusion services. 

    Get the latest on various regulatory updates, including transitioning policies with the end of the Public Health Emergency, Medicaid electronic visit verification requirements, new DMEPOS modifiers and their operational implications, the new IVIG services benefit and more.

    Attendees will also receive updates on the latest legislative efforts to fix Medicare's Part B HIT benefit as well as an initiative from Moving Health Home to address additional legislative needs.

    Talk Infusion 2023 Webinar Series Sponsored by McKesson.

    Connie Sullivan

    President & CEO

    National Home Infusion Association

    Connie Sullivan, B.S.Pharm, is the President and CEO of NHIA. Sullivan has over 25 years of infusion industry leadership, management, and clinical practice experience. Sullivan is responsible for NHIA’s advocacy initiatives and developing resources that support the infusion industry to foster innovation and promote the delivery of high-quality care. Sullivan also oversees the National Home Infusion Foundation, a 501c3 devoted to infusion research and developing future leaders. Sullivan is a member of the United States Pharmacopeia (USP) Sterile Compounding Expert Committee and currently Chairs the <797> Subcommittee. Sullivan earned her pharmacy degree from The Ohio State University in 1994.

    No Disclosures to Report

    Bill Noyes

    Sr VP of Reimbursement Policy

    NHIA

    Bill Noyes is the Senior Vice President of Reimbursement Policy at the National Home Infusion Association (NHIA). He joined NHIA in 2012 as Vice President of Health Information Policy, focusing on reimbursement and regulatory issues affecting providers' ability to do business and collect payment for their services. Noyes sits on four Medicare Contractor Advisory Councils and is the liaison to NHIA's reimbursement-focused committees. He also works closely with the NHIA government relations team to gain more meaningful Medicare coverage for home infusion. He served as Interim CEO of the associaiton from July 2018 to November 2018. Prior to joining NHIA, Noyes spent 20 years as Vice President of Operations for a multi-state home infusion provider where he was responsible for purchasing, distribution, facilities, revenue cycle management, and pharmacy operations.

    No Disclosures to Report